http://www.Gabelli.com
Invest with Us 1-800-GABELLI (800-422-3554)
Sara Wojda, Diagnostics & Life Sciences Analyst at Gabelli Funds, highlights the key takeaways from NeoGenomics’ Investor Day. NeoGenomics is a leading pure-play oncology testing company, offering an advanced and comprehensive testing menu to clinical and pharmaceutical customers globally. The company provided color into how it will be reshaping the business towards fast-growing products and markets, and will continue to be a leading cancer diagnostics player.
